Please assess the completion status of the following clinical trial:

Trial Title: QUality of Life in pAtients With Mild to modeRate Active procTitis Treated by mesalaZine (Pentasa®)

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patient aged 18 years or older.~* Patient suffering from mild to moderate active proctitis or distal proctosigmoiditis (MAYO score ≥ 3 and ≤ 10) at inclusion based on clinical and endoscopic findings within 6 months before study inclusion.~* Patient with evidence of endoscopic active proctitis or distal proctosigmoiditis (Montreal classification E1 or E2 defined by an involvement not exceeding 25 cm from the anal margin) within 6 months before study inclusion.~* Treatment of the current flare with Pentasa® to induce a remission initiated by the patient, the general practitioner or the gastroenterologist, during the inclusion visit or during the week before the inclusion visit.~* Patient having received oral and written information on the study, without any objections for the use of his/her personal data, and having signed a written Informed Consent Form.~Exclusion Criteria:~* Patient included in an interventional study assessing treatment for active proctitis or distal proctosigmoiditis.~* Patient with left sided, colitis or pancolitis.~* Patient with severe proctitis (MAYO score ≥ 11 at inclusion).~* Patient previously treated with biologics.~* Patient treated with immunosuppressive within 1 month before study inclusion.~* Patient treated with corticosteroids within 2 weeks before study inclusion.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- mesalazine (Type: None): Treatment according to standard clinical practice.

Based on this trial design, predict the completion outcome and termination type (if applicable).